The Dutch vaccination technique has encountered one other bump within the street. Uncommon instances of thrombosis could now even be linked to the Janssen vaccine. As a precautionary measure, the producer has halted all deliveries of the vaccine to Europe.
The Netherlands has ordered 11.3 million doses of the Janssen (also called Johnson & Johnson) vaccine. The Janssen vaccine affords adequate immunity from coronavirus after only one shot, which means that the nation hopes to vaccinate 11.3 million folks utilizing this vaccine.
Subsequent Thursday, the nation was set to start distributing 80,000 doses of the vaccine to healthcare employees. Whether or not or not this can go forward is unsure.
Reviews of thrombosis within the US
The choice follows reviews of low platelet counts and uncommon instances of thrombosis in girls between the age of 18 and 48 within the US. Nonetheless, the variety of instances up to now seems to be decrease than these reported after receiving the AstraZeneca vaccine.
Up to now, seven million folks have obtained the Janssen vaccine. Out of those, there have been six instances of thrombosis, bringing the danger to lower than one in one million. With the AstraZeneca vaccine, this threat is barely increased, at about one in 100 thousand.
AstraZeneca within the Netherlands
Within the Netherlands, the distribution of AstraZeneca was briefly paused following related reviews. It was then determined that solely folks over the age of 60 would obtain the vaccine because the EMA dominated the “advantages outweigh the dangers.”
Nonetheless, the Netherlands is already experiencing the damaging impression of the doubt over the usage of AstraZeneca with 40% of over 60s within the Netherlands saying that they don’t wish to obtain the vaccine.
Cupboard awaits findings of the specialists
The Dutch cupboard has no clear technique but regarding the continued distribution of the Janssen vaccine within the Netherlands.
Talking finally evening’s press convention, Minister for Well being, Hugo De Jonge, briefly talked about the vaccine. He mentioned that he was not sure of whether or not the vaccine will proceed for use within the Netherlands and it should first be decided whether or not or not it’s protected.
The Dutch cupboard will now await the findings of analysis carried out by the European Medicines Company (EMA) and the Medicines Analysis Board (MEB).
In accordance with the RIVM, vaccinations with the Janssen vaccine will proceed subsequent Thursday until one other determination is reached within the meantime.
What are your ideas on the Dutch vaccination technique? Tell us within the feedback under!
Function Picture: Janssen.com/Press Launch
The put up Deliveries of Janssen vaccine to EU halted over issues about thrombosis instances appeared first on DutchReview.